Knopp, R
In a phase 2, multicenter, randomized, placebo controlled double blind study, crizanlizumab with or without hydroxyurea (SUSTAIN study) (ClinicalTrails.gov Identifier: NCT01895361) showed that patients on the treatment arm had significantly lower rate of sickle-related pain crises compared to placebo with a lower incidence of adverse events - 10% of patients suffered from moderate side effects while one patient suffered from an intracranial bleed during treatment with this drug that could also interfere with platelet function via its effects on selectins ( Post hoc analyses showed that more patients were VOC event-free in the crizanlizumab arm than in the placebo arm, and that crizanlizumab also significantly increased time-to-first VOC compared to the placebo (ClinicalTrials.gov Identifier: NCT03814716)
Some, like alpha lipoic acid, should be used with caution
Together, our findings demonstrate the interaction between HSV-1 infection and ferroptosis and provide novel insights into the pathogenesis of HSV-1 encephalitis
Review Safety Considerations and Potential Side Effects of PT-141 Hey there, lets talk about PT-141, or as the cool kids call it, bremelanotide
While phentermine is a low-cost, short-term, generic option for people looking to lose weight, Vyvanse is focused primarily on ADHD and binge-eating disorder treatment and tends to be more expensive
